Mirvetuximab soravtansine: current and future applications
Crossref DOI link: https://doi.org/10.1186/s13045-025-01686-2
Published Online: 2025-03-18
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kong, Beihua
Zheng, Wenxin
Text and Data Mining valid from 2025-03-18
Version of Record valid from 2025-03-18
Article History
Received: 20 January 2025
Accepted: 7 March 2025
First Online: 18 March 2025
Declarations
:
: Not applicable.
: Authors’ own work, unpublished.
: The authors declare no competing interests.